Associations of sugar-and artificially sweetened soda with nonalcoholic fatty liver disease: A systematic review and meta-analysis

QJM: An International Journal of Medicine

Volumn 109, Issue 7, 2016, Pages 461-466

  Wijarnpreecha, K ^a   Thongprayoon, C ^b   Edmonds, P J ^c   Cheungpasitporn, W ^b  

^a BASSETT MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFICIALLY SWEETENED SODA; BEVERAGE; COCHRANE LIBRARY; DISEASE ASSOCIATION; EMBASE; FOOD INTAKE; HUMAN; MEDLINE; META ANALYSIS; NONALCOHOLIC FATTY LIVER; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SUGAR SWEETENED SODA; SYSTEMATIC REVIEW; CARBONATED BEVERAGE; CHEMICALLY INDUCED; INSULIN RESISTANCE; ODDS RATIO; RISK ASSESSMENT; SUGAR INTAKE;

NONNUTRITIVE SWEETENER;

CARBONATED BEVERAGES; DIETARY SUCROSE; HUMANS; INSULIN RESISTANCE; NON-ALCOHOLIC FATTY LIVER DISEASE; NON-NUTRITIVE SWEETENERS; OBSERVATIONAL STUDIES AS TOPIC; ODDS RATIO; RISK ASSESSMENT;

EID: 84977100624     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcv172     Document Type: Article

References (34)

1. Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the united states from 1988 to 2008. Clin Gastroenterol Hepatol 2011; 9:524-30.e1. quiz e560.
2. Zelber-Sagi S, Nitzan-Kaluski D, Halpern Z, Oren R. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int 2006; 26:856-63.
3. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Int Med 1997; 126:137-45.
4. Amarapurkar DN, Hashimoto E, Lesmana LA, Sollano JD, Chen PJ, Goh KL. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol 2007; 22:788-93.
5. Bray GA. Fructose and risk of cardiometabolic disease. Curr Atheroscler Rep 2012; 14:570-8.
6. Cheungpasitporn W, Thongprayoon C, Edmonds PJ, Srivali N, Ungprasert P, Kittanamongkolchai W, et al. Sugar and artificially sweetened soda consumption linked to hypertension: a systematic review and meta-analysis. Clin Exp Hypertens 2015; 19:1-7.
7. Cheungpasitporn W, Thongprayoon C, O'Corragain OA, Edmonds PJ, Kittanamongkolchai W, Erickson SB. Associations of sugar-sweetened and artificially sweetened soda with chronic kidney disease: a systematic review and meta-analysis. Nephrology 2014; 19:791-7.
8. Jimenez-Cruz A, Gomez-Miranda LM, Bacardi-Gascon M. [randomized clinical trials of the effect of sugar sweetened beverages consumption on adiposity in youngers than 16 y old; systematic review]. Nutr Hosp 2013; 28:1797-801.
9. Thongprayoon C, Laohaphan V, Srivali N. Transient ischemic attack related to sweetened beverage consumption. Am J Emerg Med 2015; 33:462.
10. Putnam JJAJ. Food Consumption, Prices, and Expenditures, Washington, DC, Food and Rural Economics Division, U.S. Department of Agriculture. Statistical BulletinNo. 965. 1970-97.
11. Duffey KJ, Popkin BM. High-fructose corn syrup: is this what's for dinner? Am J Clin Nutr 2008; 88:1722S-32S.
12. Abid A, Taha O, Nseir W, Farah R, Grosovski M, Assy N. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J Hepatol 2009; 51:918-24.
13. Assy N, Nasser G, Kamayse I, Nseir W, Beniashvili Z, Djibre A, et al. Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can J Gastroenterol 2008; 22:811-6.
14. Ma J, Fox CS, Jacques PF, Speliotes EK, Hoffmann U, Smith CE, et al. Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham heart study cohorts. J Hepatol 2015; 63:462-9.
15. Maersk M, Belza A, Stodkilde-Jorgensen H, Ringgaard S, Chabanova E, Thomsen H, et al. Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am J Clin Nutr 2012; 95:283-9.
16. Mollard RC, Senechal M, MacIntosh AC, Hay J, Wicklow BA, Wittmeier KD, et al. Dietary determinants of hepatic steatosis and visceral adiposity in overweight and obese youth at risk of type 2 diabetes. Am J Clin Nutr 2014; 99:804-12.
17. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25:603-5.
18. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-88.
19. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Bmj 2003; 327:557-60.
20. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991; 337:867-72.
21. Koch M, Borggrefe J, Barbaresko J, Groth G, Jacobs G, Siegert S, et al. Dietary patterns associated with magnetic resonance imaging-determined liver fat content in a general population study. Am J Clin Nutr 2014; 99:369-77.
22. Oddy WH, Herbison CE, Jacoby P, Ambrosini GL, O'Sullivan TA, Ayonrinde OT, et al. The western dietary pattern is prospectively associated with nonalcoholic fatty liver disease in adolescence. Am J Gastroenterol 2013; 108:778-85.
23. Vos MB, Colvin R, Belt P, Molleston JP, Murray KF, Rosenthal P, et alet al. Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD. J Pediatr Gastroenterol Nutr 2012; 54:90-6.
24. Sayon-Orea C, Martinez-Gonzalez MA, Gea A, Alonso A, Pimenta AM, Bes-Rastrollo M. Baseline consumption and changes in sugar-sweetened beverage consumption and the incidence of hypertension: the sun project. Clin Nutr 2014. In Press.
25. Carvalhana S, Machado MV, Cortez-Pinto H. Improving dietary patterns in patients with nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care 2012; 15:468-73.
26. Nomura K, Yamanouchi T. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease. J Nutr Biochem 2012; 23:203-8.
27. Nseir W, Nassar F, Assy N. Soft drinks consumption and nonalcoholic fatty liver disease. World J Gastroenterol 2010; 16:2579-88.
28. Rutledge AC, Adeli K. Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms. Nutr Rev 2007; 65:S13-23.
29. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998; 114:842-5.
30. Cirillo P, Sautin YY, Kanellis J, Kang DH, Gesualdo L, Nakagawa T, et al. Systemic inflammation, metabolic syndrome and progressive renal disease. Nephrol Dial Transplant 2009; 24:1384-7.
31. Bhatt HB, Smith RJ. Fatty liver disease in diabetes mellitus. Hepatobiliary Surg Nutr 2015; 4:101-8.
32. Mittal S, El-Serag HB, Sada YH, Kanwal F, Duan Z, Temple S, et al. Hepatocellular carcinoma in the absence of cirrhosis in US veterans is associated with non-alcoholic fatty liver disease. Clin Gastroenterol Hepatol 2015. In Press.
33. Shetty K, Chen J, Shin JH, Jogunoori W, Mishra L. Pathogenesis of hepatocellular carcinoma development in non alcoholic fatty liver disease. Curr Hepatol Rep 2015; 14:119-27.
34. Vlassara H, Cai W, Crandall J, Goldberg T, Oberstein R, Dardaine V, et al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci USA 2002; 99:15596-601.